The word “Amicogen” consists of the meaning of friend, “AMICO”
in Latin and of gene, “GENE”. We developed innovative biocatalysts
and proteins by applying our proprietary i DNA Evolution™ Technology.
We are a “Bioengineering company just like a Sincere Friend”
who contributes to the human health and the preservation of environment.
Amicogen Biotech R&D Center is expanding its R&D field based on
bio-platform technology, and researchers account for 30% of all employees.
We will lead the Industrial Biotechnology to develop new technologies
that can drive the development of humanity and society,
one step further than others.
Amicogen has developed Special Enzymes for industrial and pharmaceutical products based on the i DNA evolution™.
We want to contribute to the sustainable growth and lifelong health
of humanity by developing New Bio-Ingredientfor Health functional foods
with Special Enzymes and Protein Purification Resin.
As Amicogen started as a bio-venture company, we have focused on
the core competence of R&D and are pursuing sustainable growth
in innovative technologies and products. To increase the value
of enterprise and shareholder, we are continually strengthening our core competencies such as specialty enzyme business, healthcare, protein
purification resin business and others.
Amicogen promotes various activities to realize the value of contributing
to the protection of human health and the environment.
Amicogen is positioning itself as a global biotechnology company
through growth and leaps to create new values.
Amicogen has developed bio innovative technologies and operated the businesses that consider humankind and environment from the perspective of sustainability for the past 20 years. We will continue sustainable development based on Amicogen's environmental soundness, social responsibility and sustainable innovative technology.
Amicogen produces new technologies and values based on
creative thinking and constant technological innovation through human
oriented management. We do our best to ensure that talented individuals
with unique skills and abilities can demonstrate their abilities
according to the nature of their duties.
Amicogen produces new technologies and values based on
creative thinking and constant technological innovation through human
oriented management. We do our best to ensure that talented individuals
with unique skills and abilities can demonstrate their abilities
according to the nature of their duties.
Amicogen will try our best to maximize our shareholders' value
and realize the full potential of the company.
2023-12-06
아미코젠㈜ 구주주 청약 결과 안내
아미코젠㈜ 구주주 청약 결과 안내
2023년 12월 04일 ~ 05일 실시되었던 아미코젠(주) 유상증자 구주주 청약에 참여하여 주신 청약자 여러분께 감사드리며, 아래 청약 결과에 따라 발생한 단수주는 일반공모 청약자에게 배정하지 아니하고 대표주관회사(엔에이치투자증권㈜ 및 한양증권㈜)가 자기계산으로 인수함을 공지합니다.
▣ 발행 예정주식수 : 7,700,000주
▣ 청약 주식수 : 8,231,325주
▣ 청약률 : 106.9003247%
▣ 구주주 청약 후 발생한 단수주 : 5,462주
▣ 환불일 : 2023.12.12 (화)
▣ 납입일 : 2023.12.12 (화)
▣ 상장예정일 : 2023.12.26 (화)
F 2023년 12월 07일 ~ 08일 예정되었던 일반공모 청약은 실시하지 않습니다.
2023년 12월 06일
아미코젠 주식회사
대표이사 표 쩌